| scholarly article | Q13442814 |
| P50 | author | Guido Valesini | Q30112530 |
| P2093 | author name string | Francesca Romana Spinelli | |
| Manuela Di Franco | |||
| Alessio Metere | |||
| Cristina Iannuccelli | |||
| Francesca Boccalini | |||
| Francesco Ciciarello | |||
| Luciano Agati | |||
| Maria Chiara Gerardi | |||
| Virginia Conti | |||
| P2860 | cites work | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
| LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases | Q28141381 | ||
| Cardiovascular risk factors in women with and without rheumatoid arthritis | Q28171426 | ||
| The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism | Q28198114 | ||
| Emerging roles of apelin in biology and medicine | Q28252002 | ||
| Translational promise of the apelin--APJ system | Q28286372 | ||
| Inflammation in atherosclerosis | Q29547428 | ||
| Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation | Q30481616 | ||
| Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis | Q33570140 | ||
| Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase | Q33865641 | ||
| Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness | Q34153114 | ||
| Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? | Q34601733 | ||
| Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for V | Q34748094 | ||
| Plasma apelin is lower in patients with elevated LDL-cholesterol. | Q51467188 | ||
| Development of a disease activity score based on judgment in clinical practice by rheumatologists. | Q52399756 | ||
| The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial. | Q53988786 | ||
| Cardiovascular disease in rheumatoid arthritis | Q57307125 | ||
| HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis | Q61971712 | ||
| Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis | Q63184843 | ||
| Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study | Q71603077 | ||
| High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 | ||
| Short-term adalimumab therapy improves endo-thelial function in patients with rheumatoid arthritis refractory to infliximab | Q79996729 | ||
| Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis | Q80111107 | ||
| The novel peptide apelin regulates intrarenal artery tone in diabetic mice | Q80783907 | ||
| Cardiovascular death in rheumatoid arthritis: a population-based study | Q81484761 | ||
| Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 | ||
| Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity | Q35553196 | ||
| Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease | Q35557952 | ||
| Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity | Q35799612 | ||
| Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation | Q36465464 | ||
| Cardiovascular co-morbidity in rheumatic diseases | Q36835851 | ||
| The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications. | Q37178960 | ||
| The role of apelin in cardiovascular function and heart failure | Q37201175 | ||
| The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus | Q37206876 | ||
| Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. | Q37206972 | ||
| L-arginine analogs--inactive markers or active agents in atherogenesis? | Q37294208 | ||
| Cardiovascular co-morbidity in early rheumatoid arthritis. | Q37398086 | ||
| Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality--an update on patient populations with a wide range of cardiovascular risk | Q37549351 | ||
| Nitric oxide and oxidative stress in vascular disease | Q37715827 | ||
| Joint erosions and patients with early rheumatoid arthritis | Q40931437 | ||
| Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies | Q41918491 | ||
| Subclinical peripheral arterial disease in rheumatoid arthritis | Q43018213 | ||
| Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis. | Q43118876 | ||
| Effect of uric acid on coronary microvascular endothelial function in women: association with eGFR and ADMA. | Q43130062 | ||
| Inflammation, carotid intima-media thickness and atherosclerosis in rheumatoid arthritis | Q43216359 | ||
| Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis | Q44177928 | ||
| Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis | Q44187483 | ||
| Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. | Q45998671 | ||
| Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure | Q46477846 | ||
| Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus | Q46592249 | ||
| Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients | Q46810525 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| rheumatoid arthritis | Q187255 | ||
| P304 | page(s) | 347268 | |
| P577 | publication date | 2012-08-07 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Serum levels of asymmetric dimethylarginine and apelin as potential markers of vascular endothelial dysfunction in early rheumatoid arthritis | |
| P478 | volume | 2012 |
| Q37700750 | Adipokines as potential biomarkers in rheumatoid arthritis |
| Q37686803 | Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis. |
| Q50651982 | Assessment of ADMA, estradiol, and progesterone in severe preeclampsia. |
| Q33730073 | Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients. |
| Q64119496 | Associations between Adipokines in Arthritic Disease and Implications for Obesity |
| Q52632609 | Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis. |
| Q41366968 | Asymmetric dimethylarginine but not osteoprotegerin correlates with disease severity in patients with moderate-to-severe psoriasis undergoing anti-tumor necrosis factor-α therapy |
| Q38230867 | Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis |
| Q26739070 | Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers |
| Q85932929 | Decrease of asymmetric dimethyl arginine after anti-TNF therapy in patients with rheumatoid arthritis |
| Q33593925 | Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration |
| Q50103826 | Disease severity impacts the relationship of apelin with arterial function in patients with rheumatoid arthritis. |
| Q37260123 | Effect of therapeutic inhibition of TNF on circulating endothelial progenitor cells in patients with rheumatoid arthritis. |
| Q36412079 | Electroacupuncture with different current intensities to treat knee osteoarthritis: a single-blinded controlled study |
| Q38084462 | Importance of receptor-targeted systems in the battle against atherosclerosis. |
| Q41453068 | Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity |
| Q64097648 | Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases |
| Q59799935 | Potential role of platelets for atherosclerotic events in rheumatoid arthritis |
| Q37327034 | Relationship between asymmetric dimethylarginine and endothelial dysfunction in patients with rheumatoid arthritis |
| Q94464751 | Role of the eNOS Uncoupling and the Nitric Oxide Metabolic Pathway in the Pathogenesis of Autoimmune Rheumatic Diseases |
Search more.